Literature DB >> 16983530

Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer--a case report.

Florian Rudolf Fritzsche1, Stefan Pahl, Iver Petersen, Mick Burkhardt, Anja Dankof, Manfred Dietel, Glen Kristiansen.   

Abstract

Primary, as well as secondary, lymphomas of the breast are rare diseases and might, in some cases, be misdiagnosed as breast cancer on routine hematoxylin/eosin stainings. We report a case of an anaplastic large cell lymphoma in a 72-year-old woman with a history of breast cancer treated with breast-ablative surgery and a subsequent silicon implant 32 years ago. Clinically, she presented with an ulceration of the skin, which had developed within a few months. On conventional histology, the tumor cells were mimicking poorly differentiated invasive ductal carcinoma with a prominent leukocytic infiltrate. The immunoprofile of the tumor showed negativity for cytokeratins and led to the diagnosis of a CD30-positive anaplastic large cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983530     DOI: 10.1007/s00428-006-0287-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  26 in total

Review 1.  Breast lymphoma--a pathologic study of 14 cases.

Authors:  P H Tan; I T Sng
Journal:  Ann Acad Med Singapore       Date:  1996-11       Impact factor: 2.473

2.  Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant.

Authors:  J A Keech; B J Creech
Journal:  Plast Reconstr Surg       Date:  1997-08       Impact factor: 4.730

3.  Primary lymphoma of the breast.

Authors:  C Wiseman; K T Liao
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

4.  Lymphoma of the breast. A clinicopathologic study of primary and secondary cases.

Authors:  M Topalovski; D Crisan; J C Mattson
Journal:  Arch Pathol Lab Med       Date:  1999-12       Impact factor: 5.534

Review 5.  Primary breast lymphoma: outcome of 7 patients and a review of the literature.

Authors:  Maria Luigia Vigliotti; Matteo Dell'olio; Antonio La Sala; Nicola Di Renzo
Journal:  Leuk Lymphoma       Date:  2005-09

Review 6.  Breast lymphoma. A clinical and pathological review and 10-year treatment results.

Authors:  S Ariad; D Lewis; R Cohen; W R Bezwoda
Journal:  S Afr Med J       Date:  1995-02

7.  Cutaneous T-cell lymphoma in association with silicone breast implants.

Authors:  M Duvic; D Moore; A Menter; E C Vonderheid
Journal:  J Am Acad Dermatol       Date:  1995-06       Impact factor: 11.527

8.  Non-Hodgkin's lymphoma involving the breast.

Authors:  D A Arber; J F Simpson; L M Weiss; H Rappaport
Journal:  Am J Surg Pathol       Date:  1994-03       Impact factor: 6.394

Review 9.  Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature.

Authors:  Sunati Sahoo; Paul P Rosen; Richard M Feddersen; David S Viswanatha; Douglas A Clark; Amy Chadburn
Journal:  Arch Pathol Lab Med       Date:  2003-03       Impact factor: 5.534

10.  Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases.

Authors:  Mu-Tai Liu; Chang-Yao Hsieh; Ai-Yih Wang; Chu-Ping Pi; Tung-Hao Chang; Chia-Chun Huang; Chao-Yuan Huang
Journal:  Ann Saudi Med       Date:  2005 Jul-Aug       Impact factor: 1.526

View more
  16 in total

1.  Primary anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma of the breast in a male patient.

Authors:  E S Ko; H Seol; J H Shin; E Y Ko
Journal:  Br J Radiol       Date:  2012-04       Impact factor: 3.039

2.  Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.

Authors:  Melissa G Lechner; Stephen Lade; Daniel J Liebertz; H Miles Prince; Garry S Brody; Howard R Webster; Alan L Epstein
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 3.  Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis.

Authors:  Philip A Thompson; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

4.  Primary anaplastic large-cell lymphoma associated with breast implants.

Authors:  Leslie Popplewell; Sandra H Thomas; Qin Huang; Karen L Chang; Stephen J Forman
Journal:  Leuk Lymphoma       Date:  2011-06-24

Review 5.  Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders.

Authors:  Sara K Story; Michael K Schowalter; Larisa J Geskin
Journal:  Oncologist       Date:  2013-02-21

6.  Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls.

Authors:  Evan A Farkash; Judith A Ferry; Nancy Lee Harris; Ephraim P Hochberg; Ronald W Takvorian; Dan S Zuckerman; Aliyah R Sohani
Journal:  J Hematop       Date:  2009-08-20       Impact factor: 0.196

7.  Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases.

Authors:  Gabriela Gualco; Lucimara Chioato; William J Harrington; Lawrence M Weiss; Carlos E Bacchi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-07

8.  Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.

Authors:  Eva V George; John Pharm; Courtney Houston; Semar Al-Quran; Grey Brian; Huijia Dong; Wang Hai; Westley Reeves; Li-Jun Yang
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

9.  Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction?

Authors:  Shiyong Li; Andrew K Lee
Journal:  Int J Clin Exp Pathol       Date:  2009-10-15

10.  Secondary B-cell lymphoma diagnosed by fine-needle aspiration cytology and flow cytometry following penile carcinoma: A case report.

Authors:  Huan Wang; Lian-Nv Qiu; Mao Wu; Wan-Yuan Chen; Li-Gang Ren; Xiang-Lei He; Yong-Lie Zhou
Journal:  Oncol Lett       Date:  2016-02-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.